1,577 Shares in Humana Inc. $HUM Acquired by Caxton Associates LLP

Key Points

• Caxton Associates LLP acquired 1,577 shares of Humana Inc., valued at approximately $417,000, marking their entry into the company's stock.
• Institutional investors own 92.38% of Humana's stock, with Vanguard Group Inc. increasing its stake by 8.9%, holding over $3.69 billion in shares.
• Humana announced a quarterly dividend of $0.885 per share, with an ex-dividend date of September 26, 2023, reflecting an annualized dividend yield of 1.3%.

Caxton Associates LLP bought a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,577 shares of the insurance provider's stock, valued at approximately $417,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in Humana by 8.9% during the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock worth $3,697,222,000 after purchasing an additional 1,143,662 shares in the last quarter. Dodge & Cox grew its position in Humana by 5.5% in the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock valued at $2,845,830,000 after acquiring an additional 557,175 shares in the last quarter. Pzena Investment Management LLC grew its position in Humana by 6.1% in the first quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock valued at $1,013,133,000 after acquiring an additional 219,541 shares in the last quarter. Davis Selected Advisers grew its position in Humana by 3.3% in the first quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider's stock valued at $616,873,000 after acquiring an additional 74,434 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC grew its position in Humana by 1.6% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 1,236,936 shares of the insurance provider's stock valued at $327,293,000 after acquiring an additional 19,613 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Analyst Ratings Changes

Several analysts have issued reports on HUM shares. Truist Financial lowered their price objective on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Piper Sandler lowered their price objective on shares of Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research report on Thursday, July 31st. Barclays increased their price objective on shares of Humana from $275.00 to $315.00 and gave the company an "equal weight" rating in a research report on Friday, September 5th. Royal Bank Of Canada increased their price objective on shares of Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a research report on Thursday, August 21st. Finally, Sanford C. Bernstein increased their price objective on shares of Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a research report on Friday, September 5th. Seven analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to data from MarketBeat.com, Humana has a consensus rating of "Hold" and a consensus target price of $289.24.

Humana Stock Down 0.8%

HUM stock opened at $276.36 on Friday. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $325.75. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $33.24 billion, a P/E ratio of 21.21, a PEG ratio of 1.64 and a beta of 0.44. The firm has a 50 day simple moving average of $265.34 and a 200-day simple moving average of $257.18.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same period in the previous year, the business posted $6.96 EPS. The firm's quarterly revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana's dividend payout ratio is 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.